HUBBARD v. LANIGAN

CourtDistrict Court, D. New Jersey
DecidedJune 21, 2023
Docket3:18-cv-02055
StatusUnknown

This text of HUBBARD v. LANIGAN (HUBBARD v. LANIGAN) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HUBBARD v. LANIGAN, (D.N.J. 2023).

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

FRANK HUBBARD, Plaintitt Civil Action No. 18-2055 (MAS) (DEA) OPINION GARY LANIGAN, ef al, Defendants.

SHIPP, District Judge This matter comes before the Court on Defendants’ Motions seeking Summary Judgment in this prisoner civil rights matter. (ECF Nos. 135-36.) Plaintiff did not timely file opposition to either Motion, and instead filed a late cross-motion for summary judgment (ECF No. 138) four months after the time for responding had ended. (See ECF No. 138.) For the following reasons, Defendants’ Motions are granted, Plaintiff's Motion is denied, and judgment shall be entered in favor of Defendants as to all of Plaintiff's remaining claims. I. BACKGROUND Plaintiff filed his complaint in this matter on February 13, 2018. (ECF No. 1.) In his complaint, Plaintiff generally asserted that Defendants, state supervisory officials involved in the adoption of protocols for the treatment of state prisoners’ illnesses while in prison, had adopted policies that resulted in his being denied treatment for his Hepatitis C with direct acting antiviral drugs (DADs), such as Harvoni, which could cure the disease, resulting in pain and suffering on Plaintiff's part. Ud.) Following the Court’s screening of Plaintiffs complaint, only two claims

remain in this matter — Plaintiffs claim that Defendants were deliberately indifferent to his medical needs in violation of his Eighth Amendment rights, and a state law claim purportedly brought pursuant to N.J. Stat. Ann. § 26:2T-1. The remaining Defendants! now seek an entry of summary judgment in their favor as to both claims. (ECF Nos. 135-36.) Plaintiff did not timely file opposition, and instead filed a proposed cross-motion for summary judgment, devoid of a statement of material facts in dispute which properly responded to Defendants’ Statement of Material Facts. (ECF No. 138.) While on parole in 1981, Plaintiff shot and killed a man during a robbery, resulting in his receiving a life sentence with a twenty-five-year parole disqualifier. (ECF No. 135-2 at 1.) Plaintiff remained in prison until his release in January 2021. (U/d.) While in prison in 1999, Plaintiff contracted Hepatitis C. Ud at 2.) In 2011, the FDA approved the use of DADs to treat Hepatitis C. Ud.) Beginning in 2015, the American Association for the Study of Liver Disease and the Infectious Diseases Society of America began to recommend the use of these drugs for adults with chronic Hepatitis C. U/d.) In response, the New Jersey Department of Corrections and its contracted medical provider, Rutgers University Correctional Health Care, adopted a protocol for prisoners infected with Hepatitis C based on one implemented by the Federal Bureau of Prisons. (id. at 3.) Under this protocol, “all inmates with Hepatitis C are entered into a chronic care clinic and continually monitored, examined, and tested.” Cd.) The protocol also provides that those individuals whose disease is likely to be well treated by DADs based on a number of factors are to be placed on a list for treatment with the drugs. (/d.) The order of treatment for those placed on this waiting list for treatment with DADs is based on both the individual’s APRI score, a diagnostic device which is indicative of liver health

' An additional defendant was previously dismissed from this matter with prejudice in light of her passing. (See ECF No. 97.)

and the likelihood of developing cirrhosis, and any other diagnostic evidence of severe liver issues. (id. at 4.) Under the protocol, and in line with that adopted by the Bureau of Prisons, DADs are provided in the following priority order: first to those with the most serious conditions, those with APRI scores above 2.0 and those with cirrhosis and other serious issues; second to those with an APRI score above 1.0 receiving treatment; and finally, to those with scores between .7 and 1.0. (id.) The policy was thereafter amended in January 2018 to place all individuals with an APRI score above .7 in the second group. (/d.) Throughout his time in prison, Plaintiff received treatment for his Hepatitis C, including frequent and recurring monitoring and treatment with various antiviral therapies. (/d. at 4-5.) In December 2015, Plaintiff's first care visit following the adoption of the protocol, Plaintiff had an APRI score of .96, but had an ultrasound which indicated a normal sized liver with a “slightly lobulated appearance.” (/d. at 5.) Based on this data, Plaintiff was determined to be a candidate for treatment with DADs by Dr. Syed Husain, who recommended Plaintiff seek approval for treatment with Harvoni. (/d.) In February 2016, Plaintiff had a follow up appointment, during which he had no signs of distress, and was once again told to follow up and seek treatment. (/d.) Two weeks later, Plaintiff was seen by Dr. Ahsan, who reviewed Plaintiff's situation, ordered updated bloodwork, and returned him to the clinic to evaluate him for treatment with DADs. (/d.) Plaintiff underwent further bloodwork, returning an APRI score of .74. For the next two years, medical staff continued to monitor Plaintiff's liver condition and bloodwork, finding him to generally have an APRI score between .74 and .94, and to have no signs of distress or signs that his illness was out of control with his current course of treatment. (/d. at 5-7.) Doctors continued to suggest Plaintiff seek approval for treatment with DADs. (/d.) In April 2018, however, Plaintiff returned with bloodwork indicating an APRI score of 1.60, at which point Dr. Hussain ordered an ultrasound and “immediately approved [Plaintiff] for DAD treatment.” (/d. at 7.) Plaintiff was

prescribed DADs two days later and was treated through July 2018 with the drugs. (d.) As of November 2018, Plaintiff's blood work indicated no Hepatitis viral load. Ud. at 8.) Repeated lab work between November 2018 and Plaintiff's release indicated no viral load and that Plaintiffs illness was essentially cured with no lasting effects on Plaintiffs liver. Ud. at 8-9.) The provided medical records thus show that, until April 2018, Plaintiff remained in the lowest priority treatment group, and, upon his condition worsening, he was immediately provided with treatment with DADs, resulting in the effective curing of his disease. Il. LEGAL STANDARD Pursuant to Rule 56, a court should grant a motion for summary judgment where the record “shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). The moving party bears the initial burden of “identifying those portions of ‘the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, 1f any,’ which it believes demonstrate the absence of a genuine [dispute] of material fact.” Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986). A factual dispute is material “if it bears on an essential element of the plaintiffs claim,” and is genuine if “a reasonable jury could find in favor of the nonmoving party.” Blunt vy. Lower Merion Sch. Dist., 767 F.3d 247, 265 (3d Cir. 2014). In deciding a motion for summary judgment, a district court must “view the underlying facts and all reasonable inferences therefrom in the light most favorable to the party opposing the motion,” jd, but must not make credibility determinations or engage in any weighing of the evidence. See Anderson v. Liberty Lobby, Inc., 477 U.S. 242

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Andrews v. Camden County
95 F. Supp. 2d 217 (D. New Jersey, 2000)
Jevon Everett v. Nort
547 F. App'x 117 (Third Circuit, 2013)
Arthur Hairston, Sr. v. Director Bureau of Prisons
563 F. App'x 893 (Third Circuit, 2014)
Blunt v. Lower Merion School District
767 F.3d 247 (Third Circuit, 2014)
Natale v. Camden County Correctional Facility
318 F.3d 575 (Third Circuit, 2003)
Serodio v. Rutgers
27 F. Supp. 3d 546 (D. New Jersey, 2014)
R.J. Gaydos Insurance Agency, Inc. v. National Consumer Insurance
773 A.2d 1132 (Supreme Court of New Jersey, 2001)
United States ex rel. Walker v. Fayette County
599 F.2d 573 (Third Circuit, 1979)

Cite This Page — Counsel Stack

Bluebook (online)
HUBBARD v. LANIGAN, Counsel Stack Legal Research, https://law.counselstack.com/opinion/hubbard-v-lanigan-njd-2023.